Sriram Ryali, Chief Financial Officer at Caribou Biosciences, Inc. (CRBU), bought 17,360 shares at $1.42 ($25K) on 2025-01-29, disclosed to the SEC on 2025-01-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| EIGR | BUY | 2019-04-22 | $14K | — | Filing → |